Publications

Original Article

Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity

Cancer Vaccines

2009

Authors:

Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM and Disis ML

Journal:

Breast Cancer Research and Treatment

Volume:

113(1)

Page:

95-100

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/18236151/

Original Article

Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation

Clinical Trials

2009

Authors:

Emens LA, Asquith JM, Leatherman JM, Kobrin BJ, Petrik S, Laiko M, Levi J, Daphtary MM, Biedrzycki B, Wolff AC, Stearns V, Disis ML, Ye X, Piantadosi S, Fetting JH, Davidson NE, Jaffee EM.

Journal:

Journal of Clinical Oncology

Volume:

27(35)

Page:

5911-8

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/19805669/

Original Article

Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer

Measuring Human Immunity

2009

Authors:

Dang Y and Disis ML

Journal:

Annals of the New York Academy of Sciences

Volume:

1174

Page:

81-7

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/19769740/

Original Article

Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor

Cancer Diagnostics

2009

Authors:

Ladd J, Lu H, Taylor AD, Goodell V, Disis ML, Jiang S

Journal:

Colloids and Surfaces B: Biointerfaces

Volume:

70(1)

Page:

1-6

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/19157807/

Original Article

Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer

Cancer Diagnostics

2008

Authors:

Lu H, Goodell V, and Disis ML

Journal:

Journal of Proteome Research

Volume:

7(4)

Page:

1388-94

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/18311901/

Review Article

Immune modulation as a therapeutic strategy for non-small-cell lung cancer

2008

Authors:

Holt GE and Disis ML

Journal:

Clinical Lung Cancer

Volume:

9(1)

Page:

S13-S19

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/18540530/

Original Article

An analytical workflow for investigating cytokine profiles

Measuring Human Immunity

2008

Authors:

Siebert JC, Inokuma M, Waid DM, Pennock ND, Vaitaitis GM, Disis ML, Dunne JF, Wagner DH and Maecker HT

Journal:

Cytometry A

Volume:

73(4)

Page:

289-98

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/18163472/

Review Article

Tumor stromal barriers to the success of adoptive T cell therapy

T Cell Function & Therapy

2008

Authors:

Phan V and Disis ML

Journal:

Cancer Immunology Immunotherapy

Volume:

57(2)

Page:

281-3

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/17646987/

Methods

Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

Measuring Human Immunity

2008

Authors:

Maecker HT, Hassler J, Payne JK, Summers A, Comatas K, Ghanayem M, Morse MA, Clay TM, Lyerly HK, Bhatia S, Ghanekar SA, Maino VC, delaRosa C and Disis ML

Journal:

BMC Immunology

Volume:

Page:

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/18366814/

Review Article

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

Measuring Human Immunity

2008

Authors:

Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Hakansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL Jr, Stroncek DF, StreicherH, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM.

Journal:

Journal of Translational Medicine

Volume:

Page:

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/19105846/